Christopher Bethel

Christopher Bethel, CEO of Curate Therapeutics, brings nearly two decades of experience in technology integration and business development to the startup ecosystem. His tenure as an Executive in Residence at Biogenerator, coupled with his role as an Intrapreneur at the Merck Innovation Center, has honed his ability to skillfully merge cutting-edge technologies with strategic insights he applied to guide and mentor biotech startups from their earliest stages. At the helm of Curate Therapeutics, Chris leads the development of innovative therapies targeting advanced cancers with high mortality.

Known for his dynamic and insightful presentations, Chris excels in making complex concepts accessible and engaging. His upcoming seminar will focus on the practical application of custom GPTs and RAG models, demonstrating their transformative potential for startups. This session will not only highlight how these AI tools can solve intricate business challenges but also how they can revolutionize strategic planning and execution.

We invite all entrepreneurs and innovators to join this session. Whether you're looking to refine your business model or simply curious about the latest in AI technology, Chris’s seminar will provide valuable insights and tools to propel your venture forward. Don’t miss the opportunity to see AI in action and to learn how it can be leveraged to your advantage in the competitive landscape of startups.